This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked SVOP Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SVOP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~60.8 kDa | |
| Observed band | 72 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A15475-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | the lysates from Jurkat cells (catalog A15475-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A15475-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SVOP is predicted at 60.8 kDa, while an empirical band appears at 72 kDa; the cause of this difference is not established.
| Band near 72 kDa | Empirical SVOP band; confirm identity with peptide competition or other specificity controls |
| Band near 60.8 kDa | Near the predicted SVOP sequence mass; identity requires validation |
| Little or no band in soluble lysate | SVOP is a synaptic vesicle membrane protein and may be poorly recovered in the soluble fraction |
| Additional nearby bands | SVOP has three phosphoserine sites, but distinct phospho bands are not established |
| Predicted SVOP mass | 60.8 kDa from sequence; apparent migration may differ |
| Phosphoserine Ser25 | Modification is documented; an apparent size effect is not established |
| Phosphoserine Ser31 | Modification is documented; an apparent size effect is not established |
| Phosphoserine Ser542 | Modification is documented; an apparent size effect is not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane associated SVOP may be poorly extracted | Check membrane solubilization and test a membrane enriched fraction |
| Band higher than expected | The empirical 72 kDa band exceeds the 60.8 kDa prediction; its cause is unknown | Verify identity with peptide competition and an independent antibody |
| Band lower than expected | Identity or sample integrity is uncertain | Check protease inhibition and verify the band with an independent antibody |
| Multiple bands | Phosphoserine sites exist, but distinct phospho bands are unproven | Use peptide competition or an independent antibody to identify specific bands |
| Weak or no signal | Membrane protein recovery may be low | Check extraction efficiency and enrich the membrane fraction |
| Fragments below expected size | Sample degradation is possible | Use protease inhibitors and compare freshly prepared lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for SVOP, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-SVOP antibody, A15475-1, for Western blot with stated human, mouse, and rat reactivity. Its WB image shows Jurkat cell lysates; the supplied evidence does not show WB results for other sample types.
Which to pick: A15475-1 is the only listed option. Its WB image uses Jurkat cell lysates, so it is the directly illustrated choice for that context. Human, mouse, and rat reactivity is listed, but no other WB samples are shown.